HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chalid Assaf Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

3/2010Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.
3/2009Hepatosplenic T-cell lymphomas and therapy with TNF-alpha-blocking biologics: a risk for psoriasis patients?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chalid Assaf Research Topics

Disease

25Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2024 - 01/2006
15Neoplasms (Cancer)
02/2024 - 02/2004
14Mycosis Fungoides
11/2023 - 07/2002
12Lymphoma (Lymphomas)
01/2022 - 07/2002
3Melanoma (Melanoma, Malignant)
04/2022 - 06/2006
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 04/2007
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 04/2009
2Contact Dermatitis (Eczema, Contact)
01/2022 - 01/2022
2Neoplasm Metastasis (Metastasis)
11/2016 - 04/2015
2Disease Progression
01/2013 - 09/2007
2B-Cell Lymphoma (Lymphoma, B Cell)
06/2010 - 09/2008
2Necrosis
05/2008 - 06/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024
1Basal Cell Carcinoma (Rodent Ulcer)
03/2024
1Second Primary Neoplasms (Neoplasms, Second)
03/2024
1Sarcoma (Soft Tissue Sarcoma)
03/2024
1Diabetes Mellitus
03/2024
1Skin Neoplasms (Skin Cancer)
03/2024
1Arthritis (Polyarthritis)
02/2024
1Graft vs Host Disease (Graft-Versus-Host Disease)
02/2024
1Exanthema (Rash)
12/2023
1Anemia
12/2023
1Lymphopenia (Lymphocytopenia)
12/2023
1Dermatitis
07/2022
1Infections
01/2022
1Cytokine Release Syndrome
10/2021
1Vasculitis (Vasculitides)
09/2021
1Sezary Syndrome (Sezary Erythroderma)
01/2020
1Pain (Aches)
01/2019
1Acute Promyelocytic Leukemia
01/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2013
1Cardiotoxicity
04/2013
1Sepsis (Septicemia)
11/2012
1Bullous Pemphigoid (Pemphigoid)
07/2012
1Pemphigus (Pemphigus Vulgaris)
07/2012
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2010

Drug/Important Bio-Agent (IBA)

4T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2014 - 07/2002
4LigandsIBA
03/2010 - 06/2006
3Mechlorethamine (Nitrogen Mustard)FDA Link
07/2022 - 01/2022
3Bexarotene (LGD1069)FDA Link
01/2013 - 05/2008
2Bendamustine HydrochlorideFDA Link
01/2023 - 10/2020
2Dimethyl FumarateIBA
01/2023 - 11/2016
2pembrolizumabIBA
04/2022 - 10/2021
21,2-cyclohexanediamine (dach)IBA
01/2022 - 01/2022
2Histone Deacetylase InhibitorsIBA
08/2012 - 06/2009
2Retinoid X Receptors (Retinoid X Receptor)IBA
08/2012 - 05/2008
2Histone Deacetylases (Histone Deacetylase)IBA
08/2012 - 06/2009
2VorinostatFDA Link
08/2012 - 05/2008
2AntigensIBA
07/2012 - 05/2008
2denileukin diftitox (Ontak)FDA Link
04/2010 - 01/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 03/2009
2Death Domain ReceptorsIBA
03/2010 - 10/2007
2zanolimumabIBA
12/2008 - 04/2007
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
03/2024
1Janus Kinase InhibitorsIBA
02/2024
1mogamulizumabIBA
12/2023
1Brentuximab VedotinIBA
01/2023
1Ointments (Pastes)IBA
07/2022
1Biomarkers (Surrogate Marker)IBA
04/2022
1GemcitabineFDA Link
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1binimetinibIBA
10/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2021
1TransferasesIBA
10/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2021
1encorafenibIBA
10/2021
1Immunoglobulins (Immunoglobulin)IBA
09/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1indirubinIBA
03/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2019
1Calcitonin Gene-Related PeptideIBA
01/2019
1GlucocorticoidsIBA
01/2019
1MineralocorticoidsIBA
01/2019
1Protein Isoforms (Isoforms)IBA
11/2016
1Messenger RNA (mRNA)IBA
11/2016
1Arsenic Trioxide (Trisenox)FDA Link
01/2016
1AcidsIBA
01/2016
1RetinoidsIBA
01/2016
1Aurora Kinase AIBA
09/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013
1liposomal doxorubicin (Doxil)FDA Link
04/2013
11-dodecylpyridoxal (PLD)IBA
04/2013
1PanobinostatIBA
01/2013
1Anti-Bacterial Agents (Antibiotics)IBA
11/2012
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
08/2012
1AutoantibodiesIBA
07/2012
1ParaffinIBA
06/2010
1Interferon-gamma (Interferon, gamma)IBA
06/2010
1Recombinant Fusion ProteinsIBA
04/2010
1Interleukin-2 (IL2)IBA
04/2010

Therapy/Procedure

19Therapeutics
12/2023 - 02/2004
2Drug Therapy (Chemotherapy)
01/2022 - 04/2015
1Stem Cell Transplantation
02/2024
1Photopheresis
12/2023
1Breast Implants (Breast Implant)
01/2021
1Investigational Therapies (Experimental Therapy)
03/2019
1Treatment Delay
11/2016
1Radiotherapy
04/2015
1Combination Drug Therapy (Combination Chemotherapy)
04/2013
1Immunotherapy
06/2010